The analysis showed that for all protein expression loci, including those identified in the primary and validation analyses, the results of the IVW method, MR Egger, weighted median, simple mode, and weighted mode methods were consistent, with no significant evidence of reverse causality (detailed data in Table S5)
10.1016/j.pscychresns.2011.06.014 Psychiatry Res
Evidence of activation of the toll-like receptor-4 proinflammatory pathway in patients with schizophrenia
Dosing Comparison# Side Effects Comparison# Both share the GLP-1 agonist class side effect profile, with gastrointestinal events being most common
A slew of new medications currently in development may allow health care providers to go beyond glycemic management in the treatment of type 2 diabetes, according to a speaker
GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection